| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/02/2009 | WO2009080729A1 Oxadiazole derivatives for use as s1p1 agonists in the treatment of autoimmune and inflammatory disorders |
| 07/02/2009 | WO2009080728A1 Oxadiazole derivatives active on sphingosine-1-phosphate (sip) |
| 07/02/2009 | WO2009080725A1 Oxadiazole derivatives active on sphingosine-1-phosphate (sip) |
| 07/02/2009 | WO2009080724A1 Oxadiazole derivatives active on sphingosine-1-phosphate (s1p) |
| 07/02/2009 | WO2009080663A1 Triazole oxadiazoles derivatives |
| 07/02/2009 | WO2009080638A2 Sulfamides as zap-70 inhibitors |
| 07/02/2009 | WO2009080030A1 Treatment of autoimmune hepatitis with a once daily oral dosage form comprising tacrolimus |
| 07/02/2009 | WO2009079911A1 Pegylated erythropoietin conjugate and preparation method and uses thereof |
| 07/02/2009 | WO2009079902A1 The preparation and use of a curcumin-zinc compound and its solid dispersion |
| 07/02/2009 | WO2009079822A1 A bcg polysaccharide nucleic acid extractive and preparation method thereof |
| 07/02/2009 | WO2009079796A1 Recombinant rsv antigens |
| 07/02/2009 | WO2009079793A1 Non-aggregating human vh domains |
| 07/02/2009 | WO2009079693A1 Design and selection of medicaments that modulate the function and activity of interleukin 13 |
| 07/02/2009 | WO2009061445A3 Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction |
| 07/02/2009 | WO2009047792A3 Carbohydrate based toll-like receptor (tlr) antagonists |
| 07/02/2009 | WO2009046832A3 Short peptides used in medicine |
| 07/02/2009 | WO2009033762A3 Use of endothelin-3 as a therapeutic agent |
| 07/02/2009 | WO2009033739A3 Use of a peptide as a therapeutic agent |
| 07/02/2009 | WO2009033678A3 Use of a tuftsin as a therapeutic agent |
| 07/02/2009 | WO2009010925A3 Annelated azaheterocyclic amides containing a pyrimidine fragment and method for the production and use thereof |
| 07/02/2009 | WO2008138968A4 Dosage form comprising 10-[(3s)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10h-phenothiazine, provided in a form suitable for oral administration of a daily dose of 1 mg to 3 mg |
| 07/02/2009 | WO2008058380A8 Cancerous disease modifying antibodies |
| 07/02/2009 | US20090171103 Triptolide Derivatives for Modulation of Apoptosis and Immunosuppression |
| 07/02/2009 | US20090171086 2,4-pyrimidinediamine compounds and their uses |
| 07/02/2009 | US20090171085 N2,N4-bis(4-ethoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 07/02/2009 | US20090170941 Pharmaceutical Compounds |
| 07/02/2009 | US20090170909 N-cyclopropyl-3S-{4-methanesulfonyl-2S-[2,2,2-trifluoro-1S-(4-fluoro-phenyl)-ethylamino]-butyrylamino}-2-oxo-pentanamide; rheumatoid arthritis, multiple sclerosis, myasthenia gravis, psoriasis, pemphigus vulgaris, Graves' disease, myasthenia gravis, systemic lupus erythemotasus, asthma, pain, and atheros |
| 07/02/2009 | US20090170882 Methods and compositions |
| 07/02/2009 | US20090170881 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170853 4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent (hepatocellular cancer, colorectal cancer or non-small cell lung cancer) |
| 07/02/2009 | US20090170836 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170822 2-Methylene-20-Methyl-19,24,25,26,27-Pentanor-Vitamin D Analogs |
| 07/02/2009 | US20090170821 2-Methylene-(20S,25S)-19,26-Dinor-Vitamin D Analogs |
| 07/02/2009 | US20090170820 2-Methylene-(20S,25R)-19,26-Dinor-Vitamin D Analogs |
| 07/02/2009 | US20090170819 (20R)-23,23-Difluoro-2-Methylene-19-Nor-Bishomopregnacalciferol-Vitamin D Analogs |
| 07/02/2009 | US20090170765 Peptide for inhibition of calcineurin |
| 07/02/2009 | US20090170162 Non-coiled protective regions of pneumococcal surface proteins pspa and pspc |
| 07/02/2009 | US20090169660 A composition of radix codonopsis and radix astragali, a method for preparation thereof and its application |
| 07/02/2009 | US20090169636 Microparticles containing biodegradable polymer and cationic polysaccharide for use in immunogenic compositions |
| 07/02/2009 | US20090169612 Systemic Immune Activation Method Using Nucleic Acid-Lipid Complexes |
| 07/02/2009 | US20090169602 Allergy Treatment by Epicutaneous Allergen Administration |
| 07/02/2009 | US20090169582 Recombinant lactobacillus and use of the same |
| 07/02/2009 | US20090169579 Modified vaccinia Ankara virus avriant |
| 07/02/2009 | US20090169578 Tolerizing agents |
| 07/02/2009 | US20090169576 Influenza combinatorial antigen vaccine |
| 07/02/2009 | US20090169568 Antigenic Complex for the Diagnosis and Treatment of Porphyromonas Gingivalis Infection |
| 07/02/2009 | US20090169565 Neutrokine-alpha antibodies and methods of use thereof |
| 07/02/2009 | US20090169559 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 07/02/2009 | US20090169546 For inhibiting the release of a proinflammatory cytokine from a vertebrate cell; sepsis, rheumatoid arthritis, peritonitis, Crohn's disease, reperfusion injury, septicemia, endotoxic shock, cystic fibrosis, endocarditis, psoriasis, arthritis, anaphylactic shock, organ ischemia, reperfusion injury |
| 07/02/2009 | US20090169543 Method for regulating immune function in primates using the Foxp3 protein |
| 07/02/2009 | US20090169525 Methods of reducing transplant rejection and cardiac allograft vasculopathy by implanting autologous stem cells |
| 07/02/2009 | US20090169519 Medicinal formulation containing a combination of hiv type i and hiv type ii |
| 07/02/2009 | DE102007063056A1 New anthraquinone derivatives are protein kinase inhibitors useful e.g. to treat autoimmune-, inflammatory-, metabolic-, organ-, cardiovascular-, neurological and neurodegenerative-, hormone dependent-disease, asthma, depression and stroke |
| 07/02/2009 | CA2710600A1 Recombinant rsv antigens |
| 07/02/2009 | CA2710345A1 Triazole oxadiazoles derivatives |
| 07/02/2009 | CA2710151A1 Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9h-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as a2ar agonists |
| 07/02/2009 | CA2710130A1 Oxadiazole derivatives active on sphingosine-1-phosphate (s1p) |
| 07/02/2009 | CA2710118A1 Sulfamides as zap-70 inhibitors |
| 07/02/2009 | CA2710067A1 Oxadiazole derivatives active on sphingosine-1-phosphate (s1p) |
| 07/02/2009 | CA2710055A1 1, 2, 4 -oxadiazole compounds for the treatment of autoimmune diseases |
| 07/02/2009 | CA2708074A1 Non-aggregating human vh domains |
| 07/02/2009 | CA2707618A1 Steroid derivatives acting as glucocorticosteroid receptor agonists |
| 07/02/2009 | CA2707333A1 Crystalline form of azelastine |
| 07/02/2009 | CA2706020A1 Allergen desensitization method |
| 07/01/2009 | EP2075332A1 Cytokine production regulator gene and use thereof |
| 07/01/2009 | EP2075258A1 Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same |
| 07/01/2009 | EP2075255A1 Human FGF-23 gene and gene expression products |
| 07/01/2009 | EP2075254A1 Therapeutic use of a growth factor, NsG33 |
| 07/01/2009 | EP2075008A2 Sensitizing cells for apoptosis by selectively blocking cytokines |
| 07/01/2009 | EP2075000A1 Combination of azelastine and ciclesonide |
| 07/01/2009 | EP2074147A1 Antibodies against ccr5 and uses thereof |
| 07/01/2009 | EP2074084A1 Compounds which modulate the cb2 receptor |
| 07/01/2009 | EP2073847A2 Methods and materials for reducing risk of cold and/or flu |
| 07/01/2009 | EP2073830A1 Interferon type i supporting compounds |
| 07/01/2009 | EP1552018B1 Methods and compositions relating to gene silencing |
| 07/01/2009 | EP1537075B1 Diarylurea derivatives and their use as chloride channel blockers |
| 07/01/2009 | EP1527100B1 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 07/01/2009 | EP1471054B1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/01/2009 | EP1351967B1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/01/2009 | EP1312675B1 Protein induced by homogeneous blood transfusion and dna encoding the same |
| 07/01/2009 | EP1250154B1 G-csf conjugates |
| 07/01/2009 | EP0871748B1 Delivery of biologically active polypeptides |
| 07/01/2009 | CN100506846C Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 07/01/2009 | CN100506845C IFNAR2 mutants, their production and use |
| 07/01/2009 | CN100506831C Phosphonic acid compounds as inhibitors of serine proteases |
| 07/01/2009 | CN100506802C Formyl peptide-like acceptor-1 regulator and its Preparation and use |
| 07/01/2009 | CN100506801C Inhibitors of glycogen synthase kinase 3 |
| 07/01/2009 | CN100506791C Pentafluorosulfanylbenzoylguanidines, preparation method, their use as medicaments or diagnostic aids, and medicaments comprising them |
| 07/01/2009 | CN100506788C Arylalkylcarbamate derivatives production and use thereof in therapy |
| 07/01/2009 | CN100506277C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 07/01/2009 | CN100506229C Piperidin-2,6-dione salts and its use in the treatment of stress-related affective disorders |
| 06/30/2009 | USRE40811 Administering anti-VLA-4 antibody (or anti-VCAM-1 antibody) which blocks binding VLA-4 antigen on surface of CD34 cells to VCAM-1 or fibronectin, thereby increasing number of CD34+ cells in peripheral blood; colony stimulating factors |
| 06/30/2009 | US7553966 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/30/2009 | US7553939 Genes that encode cell surface molecules with conserved IgV and mucin domains; diagnosis or staging of cancer; treatment of an immunological disorder; detecting a predisposition to asthma |
| 06/30/2009 | US7553918 pH-sensitive polymer |
| 06/30/2009 | US7553877 Use of 2-hydroxy-1,2,3,4,4a,9,10,10a-octahydrophenanthrene compounds glucocorticoid receptor agonists to treat certain inflammatory conditions such as arthritis, asthma |
| 06/30/2009 | US7553867 Furan or thiophene derivative and medicinal use thereof |
| 06/30/2009 | US7553852 Caspase inhibitors and uses thereof |
| 06/30/2009 | US7553839 5h-pyrrolo[3,2-D] pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases |
| 06/30/2009 | US7553483 Chemokine mutants acting as chemokine antagonists |